カテゴリー： 世界, 医療/バイオ, LP Information

世界の予防喘息吸入器市場予測 2023年-2029年

【英語タイトル】Global Preventer Asthma Inhaler Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC11529）・商品コード：LP23DC11529
・発行会社（調査会社）：LP Information
・発行日：2023年11月（※2025年版があります。お問い合わせください。）
・ページ数：116
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の予防喘息吸入器市場」は、過去の販売実績から2022年の世界の予防喘息吸入器の総販売量を検討し、2023年から2029年の予測される予防喘息吸入器の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の予防喘息吸入器の市場規模を掲載し、XXX百万米ドル規模の世界の予防喘息吸入器市場の詳細な分析を提供します。本インサイトレポートは、世界の予防喘息吸入器業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の予防喘息吸入器市場における各社の独自のポジションをより深く理解するために、予防喘息吸入器製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の予防喘息吸入器市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。予防喘息吸入器の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。予防喘息吸入器の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。予防喘息吸入器のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

予防喘息吸入器の世界主要メーカーとしては、GSKpro、 3M、 Aristopharma、 Intas Pharmaceuticals、 Sensirion、 Adherium、 AstraZeneca、 Boehringer Ingelheim、 Glenmark、 Vectura、 Chiesi、 Cipla、 Hovione、 Mylan、 Merckなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の予防喘息吸入器市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では予防喘息吸入器市場をセグメンテーションし、種類別 (定量噴霧式吸入器（MDI）、呼吸作動式吸入器（BAI）、ドライパウダー吸入器（DPI）)、用途別 (個人、病院、診療所)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：定量噴霧式吸入器（MDI）、呼吸作動式吸入器（BAI）、ドライパウダー吸入器（DPI）

・用途別区分：個人、病院、診療所

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の予防喘息吸入器市場の10年間の市場状況・展望は？
・世界および地域別に見た予防喘息吸入器市場成長の要因は何か？
・予防喘息吸入器の市場機会はエンドマーケットの規模によってどのように変化するのか？
・予防喘息吸入器のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：予防喘息吸入器の年間販売量2018-2029、地域別現状・将来分析
・予防喘息吸入器の種類別セグメント：定量噴霧式吸入器（MDI）、呼吸作動式吸入器（BAI）、ドライパウダー吸入器（DPI）
・予防喘息吸入器の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・予防喘息吸入器の用途別セグメント：個人、病院、診療所
・予防喘息吸入器の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の予防喘息吸入器市場
・企業別のグローバル予防喘息吸入器市場データ：2018-2023年の年間販売量、市場シェア
・企業別の予防喘息吸入器の年間売上：2018-2023年の売上、市場シェア
・企業別の予防喘息吸入器販売価格
・主要企業の予防喘息吸入器生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

予防喘息吸入器の地域別レビュー
・地域別の予防喘息吸入器市場規模2018-2023：年間販売量、売上
・主要国別の予防喘息吸入器市場規模2018-2023：年間販売量、売上
・南北アメリカの予防喘息吸入器販売の成長
・アジア太平洋の予防喘息吸入器販売の成長
・ヨーロッパの予防喘息吸入器販売の成長
・中東・アフリカの予防喘息吸入器販売の成長

南北アメリカ市場
・南北アメリカの国別の予防喘息吸入器販売量、売上（2018-2023）
・南北アメリカの予防喘息吸入器の種類別販売量
・南北アメリカの予防喘息吸入器の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の予防喘息吸入器販売量、売上（2018-2023）
・アジア太平洋の予防喘息吸入器の種類別販売量
・アジア太平洋の予防喘息吸入器の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の予防喘息吸入器販売量、売上（2018-2023）
・ヨーロッパの予防喘息吸入器の種類別販売量
・ヨーロッパの予防喘息吸入器の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の予防喘息吸入器販売量、売上（2018-2023）
・中東・アフリカの予防喘息吸入器の種類別販売量
・中東・アフリカの予防喘息吸入器の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・予防喘息吸入器の製造コスト構造分析
・予防喘息吸入器の製造プロセス分析
・予防喘息吸入器の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・予防喘息吸入器の主要なグローバル販売業者
・予防喘息吸入器の主要なグローバル顧客

地域別の予防喘息吸入器市場予測レビュー
・地域別の予防喘息吸入器市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・予防喘息吸入器の種類別市場規模予測
・予防喘息吸入器の用途別市場規模予測

主要企業分析
GSKpro、 3M、 Aristopharma、 Intas Pharmaceuticals、 Sensirion、 Adherium、 AstraZeneca、 Boehringer Ingelheim、 Glenmark、 Vectura、 Chiesi、 Cipla、 Hovione、 Mylan、 Merck
・企業情報
・予防喘息吸入器製品
・予防喘息吸入器販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Preventer Asthma Inhaler market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Preventer Asthma Inhaler is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Preventer Asthma Inhaler is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Preventer Asthma Inhaler is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Preventer Asthma Inhaler players cover GSKpro, 3M, Aristopharma, Intas Pharmaceuticals, Sensirion, Adherium, AstraZeneca, Boehringer Ingelheim and Glenmark, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Preventer Asthma Inhaler Industry Forecast” looks at past sales and reviews total world Preventer Asthma Inhaler sales in 2022, providing a comprehensive analysis by region and market sector of projected Preventer Asthma Inhaler sales for 2023 through 2029. With Preventer Asthma Inhaler sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preventer Asthma Inhaler industry.
This Insight Report provides a comprehensive analysis of the global Preventer Asthma Inhaler landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Preventer Asthma Inhaler portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Preventer Asthma Inhaler market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preventer Asthma Inhaler and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preventer Asthma Inhaler.
This report presents a comprehensive overview, market shares, and growth opportunities of Preventer Asthma Inhaler market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Metered-dose (MDIs)
Breath-actuated Inhalers (BAIs)
Dry Powder Inhalers (DPIs)
Segmentation by application
Personal
Hospital
Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
GSKpro
3M
Aristopharma
Intas Pharmaceuticals
Sensirion
Adherium
AstraZeneca
Boehringer Ingelheim
Glenmark
Vectura
Chiesi
Cipla
Hovione
Mylan
Merck
Key Questions Addressed in this Report
What is the 10-year outlook for the global Preventer Asthma Inhaler market?
What factors are driving Preventer Asthma Inhaler market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Preventer Asthma Inhaler market opportunities vary by end market size?
How does Preventer Asthma Inhaler break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Preventer Asthma Inhaler Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Preventer Asthma Inhaler by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Preventer Asthma Inhaler by Country/Region, 2018, 2022 & 2029
2.2 Preventer Asthma Inhaler Segment by Type
2.2.1 Metered-dose (MDIs)
2.2.2 Breath-actuated Inhalers (BAIs)
2.2.3 Dry Powder Inhalers (DPIs)
2.3 Preventer Asthma Inhaler Sales by Type
2.3.1 Global Preventer Asthma Inhaler Sales Market Share by Type (2018-2023)
2.3.2 Global Preventer Asthma Inhaler Revenue and Market Share by Type (2018-2023)
2.3.3 Global Preventer Asthma Inhaler Sale Price by Type (2018-2023)
2.4 Preventer Asthma Inhaler Segment by Application
2.4.1 Personal
2.4.2 Hospital
2.4.3 Clinics
2.5 Preventer Asthma Inhaler Sales by Application
2.5.1 Global Preventer Asthma Inhaler Sale Market Share by Application (2018-2023)
2.5.2 Global Preventer Asthma Inhaler Revenue and Market Share by Application (2018-2023)
2.5.3 Global Preventer Asthma Inhaler Sale Price by Application (2018-2023)
3 Global Preventer Asthma Inhaler by Company
3.1 Global Preventer Asthma Inhaler Breakdown Data by Company
3.1.1 Global Preventer Asthma Inhaler Annual Sales by Company (2018-2023)
3.1.2 Global Preventer Asthma Inhaler Sales Market Share by Company (2018-2023)
3.2 Global Preventer Asthma Inhaler Annual Revenue by Company (2018-2023)
3.2.1 Global Preventer Asthma Inhaler Revenue by Company (2018-2023)
3.2.2 Global Preventer Asthma Inhaler Revenue Market Share by Company (2018-2023)
3.3 Global Preventer Asthma Inhaler Sale Price by Company
3.4 Key Manufacturers Preventer Asthma Inhaler Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Preventer Asthma Inhaler Product Location Distribution
3.4.2 Players Preventer Asthma Inhaler Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Preventer Asthma Inhaler by Geographic Region
4.1 World Historic Preventer Asthma Inhaler Market Size by Geographic Region (2018-2023)
4.1.1 Global Preventer Asthma Inhaler Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Preventer Asthma Inhaler Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Preventer Asthma Inhaler Market Size by Country/Region (2018-2023)
4.2.1 Global Preventer Asthma Inhaler Annual Sales by Country/Region (2018-2023)
4.2.2 Global Preventer Asthma Inhaler Annual Revenue by Country/Region (2018-2023)
4.3 Americas Preventer Asthma Inhaler Sales Growth
4.4 APAC Preventer Asthma Inhaler Sales Growth
4.5 Europe Preventer Asthma Inhaler Sales Growth
4.6 Middle East & Africa Preventer Asthma Inhaler Sales Growth
5 Americas
5.1 Americas Preventer Asthma Inhaler Sales by Country
5.1.1 Americas Preventer Asthma Inhaler Sales by Country (2018-2023)
5.1.2 Americas Preventer Asthma Inhaler Revenue by Country (2018-2023)
5.2 Americas Preventer Asthma Inhaler Sales by Type
5.3 Americas Preventer Asthma Inhaler Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Preventer Asthma Inhaler Sales by Region
6.1.1 APAC Preventer Asthma Inhaler Sales by Region (2018-2023)
6.1.2 APAC Preventer Asthma Inhaler Revenue by Region (2018-2023)
6.2 APAC Preventer Asthma Inhaler Sales by Type
6.3 APAC Preventer Asthma Inhaler Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Preventer Asthma Inhaler by Country
7.1.1 Europe Preventer Asthma Inhaler Sales by Country (2018-2023)
7.1.2 Europe Preventer Asthma Inhaler Revenue by Country (2018-2023)
7.2 Europe Preventer Asthma Inhaler Sales by Type
7.3 Europe Preventer Asthma Inhaler Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Preventer Asthma Inhaler by Country
8.1.1 Middle East & Africa Preventer Asthma Inhaler Sales by Country (2018-2023)
8.1.2 Middle East & Africa Preventer Asthma Inhaler Revenue by Country (2018-2023)
8.2 Middle East & Africa Preventer Asthma Inhaler Sales by Type
8.3 Middle East & Africa Preventer Asthma Inhaler Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Preventer Asthma Inhaler
10.3 Manufacturing Process Analysis of Preventer Asthma Inhaler
10.4 Industry Chain Structure of Preventer Asthma Inhaler
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Preventer Asthma Inhaler Distributors
11.3 Preventer Asthma Inhaler Customer
12 World Forecast Review for Preventer Asthma Inhaler by Geographic Region
12.1 Global Preventer Asthma Inhaler Market Size Forecast by Region
12.1.1 Global Preventer Asthma Inhaler Forecast by Region (2024-2029)
12.1.2 Global Preventer Asthma Inhaler Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Preventer Asthma Inhaler Forecast by Type
12.7 Global Preventer Asthma Inhaler Forecast by Application
13 Key Players Analysis
13.1 GSKpro
13.1.1 GSKpro Company Information
13.1.2 GSKpro Preventer Asthma Inhaler Product Portfolios and Specifications
13.1.3 GSKpro Preventer Asthma Inhaler Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GSKpro Main Business Overview
13.1.5 GSKpro Latest Developments
13.2 3M
13.2.1 3M Company Information
13.2.2 3M Preventer Asthma Inhaler Product Portfolios and Specifications
13.2.3 3M Preventer Asthma Inhaler Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 3M Main Business Overview
13.2.5 3M Latest Developments
13.3 Aristopharma
13.3.1 Aristopharma Company Information
13.3.2 Aristopharma Preventer Asthma Inhaler Product Portfolios and Specifications
13.3.3 Aristopharma Preventer Asthma Inhaler Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Aristopharma Main Business Overview
13.3.5 Aristopharma Latest Developments
13.4 Intas Pharmaceuticals
13.4.1 Intas Pharmaceuticals Company Information
13.4.2 Intas Pharmaceuticals Preventer Asthma Inhaler Product Portfolios and Specifications
13.4.3 Intas Pharmaceuticals Preventer Asthma Inhaler Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Intas Pharmaceuticals Main Business Overview
13.4.5 Intas Pharmaceuticals Latest Developments
13.5 Sensirion
13.5.1 Sensirion Company Information
13.5.2 Sensirion Preventer Asthma Inhaler Product Portfolios and Specifications
13.5.3 Sensirion Preventer Asthma Inhaler Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sensirion Main Business Overview
13.5.5 Sensirion Latest Developments
13.6 Adherium
13.6.1 Adherium Company Information
13.6.2 Adherium Preventer Asthma Inhaler Product Portfolios and Specifications
13.6.3 Adherium Preventer Asthma Inhaler Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Adherium Main Business Overview
13.6.5 Adherium Latest Developments
13.7 AstraZeneca
13.7.1 AstraZeneca Company Information
13.7.2 AstraZeneca Preventer Asthma Inhaler Product Portfolios and Specifications
13.7.3 AstraZeneca Preventer Asthma Inhaler Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 AstraZeneca Main Business Overview
13.7.5 AstraZeneca Latest Developments
13.8 Boehringer Ingelheim
13.8.1 Boehringer Ingelheim Company Information
13.8.2 Boehringer Ingelheim Preventer Asthma Inhaler Product Portfolios and Specifications
13.8.3 Boehringer Ingelheim Preventer Asthma Inhaler Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Boehringer Ingelheim Main Business Overview
13.8.5 Boehringer Ingelheim Latest Developments
13.9 Glenmark
13.9.1 Glenmark Company Information
13.9.2 Glenmark Preventer Asthma Inhaler Product Portfolios and Specifications
13.9.3 Glenmark Preventer Asthma Inhaler Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Glenmark Main Business Overview
13.9.5 Glenmark Latest Developments
13.10 Vectura
13.10.1 Vectura Company Information
13.10.2 Vectura Preventer Asthma Inhaler Product Portfolios and Specifications
13.10.3 Vectura Preventer Asthma Inhaler Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Vectura Main Business Overview
13.10.5 Vectura Latest Developments
13.11 Chiesi
13.11.1 Chiesi Company Information
13.11.2 Chiesi Preventer Asthma Inhaler Product Portfolios and Specifications
13.11.3 Chiesi Preventer Asthma Inhaler Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Chiesi Main Business Overview
13.11.5 Chiesi Latest Developments
13.12 Cipla
13.12.1 Cipla Company Information
13.12.2 Cipla Preventer Asthma Inhaler Product Portfolios and Specifications
13.12.3 Cipla Preventer Asthma Inhaler Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Cipla Main Business Overview
13.12.5 Cipla Latest Developments
13.13 Hovione
13.13.1 Hovione Company Information
13.13.2 Hovione Preventer Asthma Inhaler Product Portfolios and Specifications
13.13.3 Hovione Preventer Asthma Inhaler Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Hovione Main Business Overview
13.13.5 Hovione Latest Developments
13.14 Mylan
13.14.1 Mylan Company Information
13.14.2 Mylan Preventer Asthma Inhaler Product Portfolios and Specifications
13.14.3 Mylan Preventer Asthma Inhaler Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Mylan Main Business Overview
13.14.5 Mylan Latest Developments
13.15 Merck
13.15.1 Merck Company Information
13.15.2 Merck Preventer Asthma Inhaler Product Portfolios and Specifications
13.15.3 Merck Preventer Asthma Inhaler Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Merck Main Business Overview
13.15.5 Merck Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Preventer Asthma Inhaler Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Preventer Asthma Inhaler Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Metered-dose (MDIs)
Table 4. Major Players of Breath-actuated Inhalers (BAIs)
Table 5. Major Players of Dry Powder Inhalers (DPIs)
Table 6. Global Preventer Asthma Inhaler Sales by Type (2018-2023) & (K Units)
Table 7. Global Preventer Asthma Inhaler Sales Market Share by Type (2018-2023)
Table 8. Global Preventer Asthma Inhaler Revenue by Type (2018-2023) & ($ million)
Table 9. Global Preventer Asthma Inhaler Revenue Market Share by Type (2018-2023)
Table 10. Global Preventer Asthma Inhaler Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Preventer Asthma Inhaler Sales by Application (2018-2023) & (K Units)
Table 12. Global Preventer Asthma Inhaler Sales Market Share by Application (2018-2023)
Table 13. Global Preventer Asthma Inhaler Revenue by Application (2018-2023)
Table 14. Global Preventer Asthma Inhaler Revenue Market Share by Application (2018-2023)
Table 15. Global Preventer Asthma Inhaler Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Preventer Asthma Inhaler Sales by Company (2018-2023) & (K Units)
Table 17. Global Preventer Asthma Inhaler Sales Market Share by Company (2018-2023)
Table 18. Global Preventer Asthma Inhaler Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Preventer Asthma Inhaler Revenue Market Share by Company (2018-2023)
Table 20. Global Preventer Asthma Inhaler Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Preventer Asthma Inhaler Producing Area Distribution and Sales Area
Table 22. Players Preventer Asthma Inhaler Products Offered
Table 23. Preventer Asthma Inhaler Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Preventer Asthma Inhaler Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Preventer Asthma Inhaler Sales Market Share Geographic Region (2018-2023)
Table 28. Global Preventer Asthma Inhaler Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Preventer Asthma Inhaler Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Preventer Asthma Inhaler Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Preventer Asthma Inhaler Sales Market Share by Country/Region (2018-2023)
Table 32. Global Preventer Asthma Inhaler Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Preventer Asthma Inhaler Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Preventer Asthma Inhaler Sales by Country (2018-2023) & (K Units)
Table 35. Americas Preventer Asthma Inhaler Sales Market Share by Country (2018-2023)
Table 36. Americas Preventer Asthma Inhaler Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Preventer Asthma Inhaler Revenue Market Share by Country (2018-2023)
Table 38. Americas Preventer Asthma Inhaler Sales by Type (2018-2023) & (K Units)
Table 39. Americas Preventer Asthma Inhaler Sales by Application (2018-2023) & (K Units)
Table 40. APAC Preventer Asthma Inhaler Sales by Region (2018-2023) & (K Units)
Table 41. APAC Preventer Asthma Inhaler Sales Market Share by Region (2018-2023)
Table 42. APAC Preventer Asthma Inhaler Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Preventer Asthma Inhaler Revenue Market Share by Region (2018-2023)
Table 44. APAC Preventer Asthma Inhaler Sales by Type (2018-2023) & (K Units)
Table 45. APAC Preventer Asthma Inhaler Sales by Application (2018-2023) & (K Units)
Table 46. Europe Preventer Asthma Inhaler Sales by Country (2018-2023) & (K Units)
Table 47. Europe Preventer Asthma Inhaler Sales Market Share by Country (2018-2023)
Table 48. Europe Preventer Asthma Inhaler Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Preventer Asthma Inhaler Revenue Market Share by Country (2018-2023)
Table 50. Europe Preventer Asthma Inhaler Sales by Type (2018-2023) & (K Units)
Table 51. Europe Preventer Asthma Inhaler Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Preventer Asthma Inhaler Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Preventer Asthma Inhaler Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Preventer Asthma Inhaler Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Preventer Asthma Inhaler Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Preventer Asthma Inhaler Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Preventer Asthma Inhaler Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Preventer Asthma Inhaler
Table 59. Key Market Challenges & Risks of Preventer Asthma Inhaler
Table 60. Key Industry Trends of Preventer Asthma Inhaler
Table 61. Preventer Asthma Inhaler Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Preventer Asthma Inhaler Distributors List
Table 64. Preventer Asthma Inhaler Customer List
Table 65. Global Preventer Asthma Inhaler Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Preventer Asthma Inhaler Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Preventer Asthma Inhaler Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Preventer Asthma Inhaler Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Preventer Asthma Inhaler Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Preventer Asthma Inhaler Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Preventer Asthma Inhaler Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Preventer Asthma Inhaler Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Preventer Asthma Inhaler Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Preventer Asthma Inhaler Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Preventer Asthma Inhaler Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Preventer Asthma Inhaler Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Preventer Asthma Inhaler Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Preventer Asthma Inhaler Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. GSKpro Basic Information, Preventer Asthma Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 80. GSKpro Preventer Asthma Inhaler Product Portfolios and Specifications
Table 81. GSKpro Preventer Asthma Inhaler Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. GSKpro Main Business
Table 83. GSKpro Latest Developments
Table 84. 3M Basic Information, Preventer Asthma Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 85. 3M Preventer Asthma Inhaler Product Portfolios and Specifications
Table 86. 3M Preventer Asthma Inhaler Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. 3M Main Business
Table 88. 3M Latest Developments
Table 89. Aristopharma Basic Information, Preventer Asthma Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 90. Aristopharma Preventer Asthma Inhaler Product Portfolios and Specifications
Table 91. Aristopharma Preventer Asthma Inhaler Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Aristopharma Main Business
Table 93. Aristopharma Latest Developments
Table 94. Intas Pharmaceuticals Basic Information, Preventer Asthma Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 95. Intas Pharmaceuticals Preventer Asthma Inhaler Product Portfolios and Specifications
Table 96. Intas Pharmaceuticals Preventer Asthma Inhaler Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Intas Pharmaceuticals Main Business
Table 98. Intas Pharmaceuticals Latest Developments
Table 99. Sensirion Basic Information, Preventer Asthma Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 100. Sensirion Preventer Asthma Inhaler Product Portfolios and Specifications
Table 101. Sensirion Preventer Asthma Inhaler Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Sensirion Main Business
Table 103. Sensirion Latest Developments
Table 104. Adherium Basic Information, Preventer Asthma Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 105. Adherium Preventer Asthma Inhaler Product Portfolios and Specifications
Table 106. Adherium Preventer Asthma Inhaler Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Adherium Main Business
Table 108. Adherium Latest Developments
Table 109. AstraZeneca Basic Information, Preventer Asthma Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 110. AstraZeneca Preventer Asthma Inhaler Product Portfolios and Specifications
Table 111. AstraZeneca Preventer Asthma Inhaler Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. AstraZeneca Main Business
Table 113. AstraZeneca Latest Developments
Table 114. Boehringer Ingelheim Basic Information, Preventer Asthma Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 115. Boehringer Ingelheim Preventer Asthma Inhaler Product Portfolios and Specifications
Table 116. Boehringer Ingelheim Preventer Asthma Inhaler Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Boehringer Ingelheim Main Business
Table 118. Boehringer Ingelheim Latest Developments
Table 119. Glenmark Basic Information, Preventer Asthma Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 120. Glenmark Preventer Asthma Inhaler Product Portfolios and Specifications
Table 121. Glenmark Preventer Asthma Inhaler Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Glenmark Main Business
Table 123. Glenmark Latest Developments
Table 124. Vectura Basic Information, Preventer Asthma Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 125. Vectura Preventer Asthma Inhaler Product Portfolios and Specifications
Table 126. Vectura Preventer Asthma Inhaler Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Vectura Main Business
Table 128. Vectura Latest Developments
Table 129. Chiesi Basic Information, Preventer Asthma Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 130. Chiesi Preventer Asthma Inhaler Product Portfolios and Specifications
Table 131. Chiesi Preventer Asthma Inhaler Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Chiesi Main Business
Table 133. Chiesi Latest Developments
Table 134. Cipla Basic Information, Preventer Asthma Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 135. Cipla Preventer Asthma Inhaler Product Portfolios and Specifications
Table 136. Cipla Preventer Asthma Inhaler Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Cipla Main Business
Table 138. Cipla Latest Developments
Table 139. Hovione Basic Information, Preventer Asthma Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 140. Hovione Preventer Asthma Inhaler Product Portfolios and Specifications
Table 141. Hovione Preventer Asthma Inhaler Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Hovione Main Business
Table 143. Hovione Latest Developments
Table 144. Mylan Basic Information, Preventer Asthma Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 145. Mylan Preventer Asthma Inhaler Product Portfolios and Specifications
Table 146. Mylan Preventer Asthma Inhaler Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Mylan Main Business
Table 148. Mylan Latest Developments
Table 149. Merck Basic Information, Preventer Asthma Inhaler Manufacturing Base, Sales Area and Its Competitors
Table 150. Merck Preventer Asthma Inhaler Product Portfolios and Specifications
Table 151. Merck Preventer Asthma Inhaler Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Merck Main Business
Table 153. Merck Latest Developments
List of Figures
Figure 1. Picture of Preventer Asthma Inhaler
Figure 2. Preventer Asthma Inhaler Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Preventer Asthma Inhaler Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Preventer Asthma Inhaler Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Preventer Asthma Inhaler Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Metered-dose (MDIs)
Figure 10. Product Picture of Breath-actuated Inhalers (BAIs)
Figure 11. Product Picture of Dry Powder Inhalers (DPIs)
Figure 12. Global Preventer Asthma Inhaler Sales Market Share by Type in 2022
Figure 13. Global Preventer Asthma Inhaler Revenue Market Share by Type (2018-2023)
Figure 14. Preventer Asthma Inhaler Consumed in Personal
Figure 15. Global Preventer Asthma Inhaler Market: Personal (2018-2023) & (K Units)
Figure 16. Preventer Asthma Inhaler Consumed in Hospital
Figure 17. Global Preventer Asthma Inhaler Market: Hospital (2018-2023) & (K Units)
Figure 18. Preventer Asthma Inhaler Consumed in Clinics
Figure 19. Global Preventer Asthma Inhaler Market: Clinics (2018-2023) & (K Units)
Figure 20. Global Preventer Asthma Inhaler Sales Market Share by Application (2022)
Figure 21. Global Preventer Asthma Inhaler Revenue Market Share by Application in 2022
Figure 22. Preventer Asthma Inhaler Sales Market by Company in 2022 (K Units)
Figure 23. Global Preventer Asthma Inhaler Sales Market Share by Company in 2022
Figure 24. Preventer Asthma Inhaler Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Preventer Asthma Inhaler Revenue Market Share by Company in 2022
Figure 26. Global Preventer Asthma Inhaler Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Preventer Asthma Inhaler Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Preventer Asthma Inhaler Sales 2018-2023 (K Units)
Figure 29. Americas Preventer Asthma Inhaler Revenue 2018-2023 ($ Millions)
Figure 30. APAC Preventer Asthma Inhaler Sales 2018-2023 (K Units)
Figure 31. APAC Preventer Asthma Inhaler Revenue 2018-2023 ($ Millions)
Figure 32. Europe Preventer Asthma Inhaler Sales 2018-2023 (K Units)
Figure 33. Europe Preventer Asthma Inhaler Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Preventer Asthma Inhaler Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Preventer Asthma Inhaler Revenue 2018-2023 ($ Millions)
Figure 36. Americas Preventer Asthma Inhaler Sales Market Share by Country in 2022
Figure 37. Americas Preventer Asthma Inhaler Revenue Market Share by Country in 2022
Figure 38. Americas Preventer Asthma Inhaler Sales Market Share by Type (2018-2023)
Figure 39. Americas Preventer Asthma Inhaler Sales Market Share by Application (2018-2023)
Figure 40. United States Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Preventer Asthma Inhaler Sales Market Share by Region in 2022
Figure 45. APAC Preventer Asthma Inhaler Revenue Market Share by Regions in 2022
Figure 46. APAC Preventer Asthma Inhaler Sales Market Share by Type (2018-2023)
Figure 47. APAC Preventer Asthma Inhaler Sales Market Share by Application (2018-2023)
Figure 48. China Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Preventer Asthma Inhaler Sales Market Share by Country in 2022
Figure 56. Europe Preventer Asthma Inhaler Revenue Market Share by Country in 2022
Figure 57. Europe Preventer Asthma Inhaler Sales Market Share by Type (2018-2023)
Figure 58. Europe Preventer Asthma Inhaler Sales Market Share by Application (2018-2023)
Figure 59. Germany Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Preventer Asthma Inhaler Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Preventer Asthma Inhaler Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Preventer Asthma Inhaler Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Preventer Asthma Inhaler Sales Market Share by Application (2018-2023)
Figure 68. Egypt Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Preventer Asthma Inhaler Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Preventer Asthma Inhaler in 2022
Figure 74. Manufacturing Process Analysis of Preventer Asthma Inhaler
Figure 75. Industry Chain Structure of Preventer Asthma Inhaler
Figure 76. Channels of Distribution
Figure 77. Global Preventer Asthma Inhaler Sales Market Forecast by Region (2024-2029)
Figure 78. Global Preventer Asthma Inhaler Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Preventer Asthma Inhaler Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Preventer Asthma Inhaler Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Preventer Asthma Inhaler Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Preventer Asthma Inhaler Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の予防喘息吸入器市場予測 2023年-2029年] (コード：LP23DC11529)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の予防喘息吸入器市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の喘息用スマート吸入器市場予測 2023年-2029年
  • 世界の喘息用スマート吸入器市場予測 2023年-2029年
  • 世界の定量吸入器スペーサー市場予測 2023年-2029年
  • 世界の空気吸入器市場予測 2023年-2029年
  • 世界の喘息&COPD診断市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆